Literature DB >> 19403934

Brain metastases and subtypes of breast cancer.

B C Pestalozzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19403934     DOI： 10.1093/annonc/mdp246

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  17 in total

Review 1.  Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?

Authors:  Amy B Heimberger; John H Sampson
Journal:  Neuro Oncol       Date:  2010-12-10       Impact factor: 12.300

Review 2.  Systemic Therapy for HER2-Positive Central Nervous System Disease: Where We Are and Where Do We Go From Here?

Authors:  Eleonora Teplinsky; Francisco J Esteva
Journal:  Curr Oncol Rep       Date:  2015-10       Impact factor: 5.075

3.  A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases.

Authors:  Rachel A Freedman; Elizabeth Bullitt; Lixian Sun; Rebecca Gelman; Gordon Harris; Jennifer A Ligibel; Ian E Krop; Ann H Partridge; Emily Eisenberg; Eric P Winer; Nancy U Lin
Journal:  Clin Breast Cancer       Date:  2011-06-22       Impact factor: 3.225

4.  Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases.

Authors:  Ishwaria M Subbiah; Xiudong Lei; Jeffrey S Weinberg; Erik P Sulman; Mariana Chavez-MacGregor; Debu Tripathy; Rohan Gupta; Ankur Varma; Jay Chouhan; Richard P Guevarra; Vicente Valero; Mark R Gilbert; Ana M Gonzalez-Angulo
Journal:  J Clin Oncol       Date:  2015-05-18       Impact factor: 44.544

5.  Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer.

Authors:  Amélie Darlix; Gaia Griguolo; Simon Thezenas; Eva Kantelhardt; Christoph Thomssen; Maria Vittoria Dieci; Federica Miglietta; PierFranco Conte; Antoine Laurent Braccini; Jean Marc Ferrero; Caroline Bailleux; William Jacot; Valentina Guarneri
Journal:  J Neurooncol       Date:  2018-02-27       Impact factor: 4.130

6.  Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.

Authors:  Rachel A Freedman; Rebecca S Gelman; Jeffrey S Wefel; Michelle E Melisko; Kenneth R Hess; Roisin M Connolly; Catherine H Van Poznak; Polly A Niravath; Shannon L Puhalla; Nuhad Ibrahim; Kimberly L Blackwell; Beverly Moy; Christina Herold; Minetta C Liu; Alarice Lowe; Nathalie Y R Agar; Nicole Ryabin; Sarah Farooq; Elizabeth Lawler; Mothaffar F Rimawi; Ian E Krop; Antonio C Wolff; Eric P Winer; Nancy U Lin
Journal:  J Clin Oncol       Date:  2016-02-01       Impact factor: 44.544

7.  Astrocyte-induced Reelin expression drives proliferation of Her2+ breast cancer metastases.

Authors:  Rahul Jandial; Cecilia Choy; Danielle M Levy; Mike Y Chen; Khairul I Ansari
Journal:  Clin Exp Metastasis       Date:  2017-02-17       Impact factor: 5.150

8.  Brain metastases free survival differs between breast cancer subtypes.

Authors:  A Berghoff; Z Bago-Horvath; C De Vries; P Dubsky; U Pluschnig; M Rudas; A Rottenfusser; M Knauer; H Eiter; F Fitzal; K Dieckmann; R M Mader; M Gnant; C C Zielinski; G G Steger; M Preusser; R Bartsch
Journal:  Br J Cancer       Date:  2012-01-10       Impact factor: 7.640

9.  Understanding Heterogeneity and Permeability of Brain Metastases in Murine Models of HER2-Positive Breast Cancer Through Magnetic Resonance Imaging: Implications for Detection and Therapy.

Authors:  Donna H Murrell; Amanda M Hamilton; Christiane L Mallett; Robbert van Gorkum; Ann F Chambers; Paula J Foster
Journal:  Transl Oncol       Date:  2015-06       Impact factor: 4.243

Review 10.  Role of the blood-brain barrier in the formation of brain metastases.

Authors:  Imola Wilhelm; Judit Molnár; Csilla Fazakas; János Haskó; István A Krizbai
Journal:  Int J Mol Sci       Date:  2013-01-11       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.